‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
The independent source for health policy research, polling, and news.
7,441 - 7,460 of 15,442 Results
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
As more patients receive hospice care at home, some of the powerful, addictive drugs they’re prescribed are ending up in the wrong hands.
The governors of both states signed abortion legislation last week. Texas will restrict insurance coverage while Oregon will require that it be covered.
A program that provides $400 million in federal funding for the visits expires next month. Advocates and providers hope it will be reauthorized with a higher level of funding — but some worry that might not happen.
Oregon court says Alzheimer’s patient Nora Harris must be spoon-fed. But her husband says she never wanted to live like this.
Three-quarters of participants in a newly released study said they did not know of resources for comparing health care costs, while half said that if a website were available to provide such information, they would use it.
One Kentucky program is eyed by other jurisdictions as a way to get addicted parents into recovery and help them care for their children at home.
This is the first federal website designed to help families choose a hospice, but experts aren’t impressed.
New research suggests that efforts to address climbing rates of rural suicide must focus on safe access to firearms. State-based coalitions are attempting just that.
In this episode of “What the Health?” Mary Agnes Carey of Kaiser Health News, Sarah Karlin-Smith of Politico, Margot Sanger-Katz of The New York Times and Julie Appleby of Kaiser Health News discuss the recent extension of cost-sharing subsidies for millions of low-income beneficiaries on the Affordable Care Act’s marketplaces and the state of play on Capitol Hill and in the states concerning initiatives to lower prescription drug costs.
When leaders in Washington discuss the future of American health care, women are not always in the room. Here, nine women share their personal stories, fears and hopes.
Growing numbers of physicians say they support a single-payer health care system, a 180-degree turn in opinion over a decade.
The change would not be expected to have much long-term effect on the number of uninsured people. But it could cause a shift in which plans are popular with marketplace customers.
Individuals who require very specialized care for their health are advised to make their case when a plan doesn’t cover their doctor.
In the first year of payments for advance-care planning sessions, once decried as ”death panels,“ use is higher than expected, new data show.
Medicaid spent billions more in 2016 than the year before on decades-old prescription drugs, including many generics, a Kaiser Health News data analysis shows.
Kaiser Health News gives readers a chance to respond, react and comment on our stories.
Heather Menzel thought returning to her rural California hometown was the answer to her addiction problems. Then she discovered the town had no medical treatment options for her — but plenty of heroin.
As the link between obesity and depression becomes increasingly clear, so do the challenges of treating these distinct chronic conditions together.
Majorities of Democrats and Republicans — and people who say they are supporters of President Donald Trump — say they want the country to make the law successful.
© 2026 KFF